Original
Evaluación económica de la restricción del uso de piroxicam en España
Economic evaluation of the restriction in the use piroxicam in Spain
Miguel-Ángel Maciá Martínez
División de Farmacoepidemiología y Farmacovigilancia, Departamento de Medicamentos de Uso Humano, Agencia Española de Medicamentos y Productos Sanitarios, Ministerio de Sanidad, Servicios Sociales e Igualdad, Madrid, España
Leído
11889
Vecesse ha leído el artículo
3389
Total PDF
8500
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 2 | 1 | 3 |
| 2025 5 | 122 | 63 | 185 |
| 2025 4 | 115 | 46 | 161 |
| 2025 3 | 106 | 45 | 151 |
| 2025 2 | 113 | 39 | 152 |
| 2025 1 | 70 | 57 | 127 |
| 2024 12 | 62 | 28 | 90 |
| 2024 11 | 78 | 67 | 145 |
| 2024 10 | 61 | 23 | 84 |
| 2024 9 | 176 | 22 | 198 |
| 2024 8 | 63 | 44 | 107 |
| 2024 7 | 67 | 27 | 94 |
| 2024 6 | 78 | 21 | 99 |
| 2024 5 | 101 | 38 | 139 |
| 2024 4 | 79 | 20 | 99 |
| 2024 3 | 78 | 30 | 108 |
| 2024 2 | 54 | 19 | 73 |
| 2024 1 | 72 | 33 | 105 |
| 2023 12 | 65 | 13 | 78 |
| 2023 11 | 76 | 34 | 110 |
| 2023 10 | 95 | 32 | 127 |
| 2023 9 | 178 | 26 | 204 |
| 2023 8 | 67 | 20 | 87 |
| 2023 7 | 71 | 30 | 101 |
| 2023 6 | 99 | 27 | 126 |
| 2023 5 | 118 | 31 | 149 |
| 2023 4 | 76 | 12 | 88 |
| 2023 3 | 111 | 37 | 148 |
| 2023 2 | 96 | 38 | 134 |
| 2022 1 | 73 | 25 | 98 |
| 2022 12 | 106 | 33 | 139 |
| 2022 11 | 92 | 44 | 136 |
| 2022 10 | 127 | 40 | 167 |
| 2022 9 | 84 | 33 | 117 |
| 2022 8 | 62 | 68 | 130 |
| 2022 7 | 62 | 52 | 114 |
| 2022 6 | 50 | 27 | 77 |
| 2022 5 | 104 | 49 | 153 |
| 2022 4 | 63 | 41 | 104 |
| 2022 3 | 68 | 58 | 126 |
| 2022 2 | 55 | 31 | 86 |
| 2021 1 | 57 | 34 | 91 |
| 2021 12 | 73 | 53 | 126 |
| 2021 11 | 80 | 51 | 131 |
| 2021 10 | 102 | 55 | 157 |
| 2021 9 | 62 | 50 | 112 |
| 2021 8 | 81 | 37 | 118 |
| 2021 7 | 73 | 41 | 114 |
| 2021 6 | 78 | 41 | 119 |
| 2021 5 | 72 | 40 | 112 |
| 2021 4 | 202 | 51 | 253 |
| 2021 3 | 88 | 23 | 111 |
| 2021 2 | 91 | 18 | 109 |
| 2020 1 | 78 | 29 | 107 |
| 2020 12 | 79 | 12 | 91 |
| 2020 11 | 136 | 24 | 160 |
| 2020 10 | 89 | 22 | 111 |
| 2020 9 | 88 | 19 | 107 |
| 2020 8 | 62 | 18 | 80 |
| 2020 7 | 84 | 22 | 106 |
| 2020 6 | 101 | 23 | 124 |
| 2020 5 | 156 | 22 | 178 |
| 2020 4 | 122 | 45 | 167 |
| 2020 3 | 97 | 43 | 140 |
| 2020 2 | 117 | 36 | 153 |
| 2020 1 | 74 | 37 | 111 |
| 2019 12 | 77 | 25 | 102 |
| 2019 11 | 85 | 34 | 119 |
| 2019 10 | 116 | 27 | 143 |
| 2019 9 | 171 | 28 | 199 |
| 2019 8 | 92 | 43 | 135 |
| 2019 7 | 67 | 33 | 100 |
| 2019 6 | 70 | 35 | 105 |
| 2019 5 | 83 | 90 | 173 |
| 2019 4 | 70 | 123 | 193 |
| 2019 3 | 75 | 27 | 102 |
| 2019 2 | 44 | 16 | 60 |
| 2019 1 | 50 | 29 | 79 |
| 2018 12 | 118 | 59 | 177 |
| 2018 11 | 147 | 16 | 163 |
| 2018 10 | 129 | 14 | 143 |
| 2018 9 | 44 | 9 | 53 |
| 2018 8 | 38 | 16 | 54 |
| 2018 7 | 27 | 6 | 33 |
| 2018 5 | 4 | 1 | 5 |
| 2018 4 | 43 | 7 | 50 |
| 2018 3 | 56 | 6 | 62 |
| 2018 2 | 36 | 12 | 48 |
| 2018 1 | 26 | 4 | 30 |
| 2017 12 | 41 | 12 | 53 |
| 2017 11 | 37 | 14 | 51 |
| 2017 10 | 36 | 12 | 48 |
| 2017 9 | 38 | 11 | 49 |
| 2017 8 | 43 | 14 | 57 |
| 2017 7 | 42 | 7 | 49 |
| 2017 6 | 57 | 23 | 80 |
| 2017 5 | 61 | 16 | 77 |
| 2017 4 | 46 | 11 | 57 |
| 2017 3 | 25 | 12 | 37 |
| 2017 2 | 26 | 9 | 35 |
| 2016 1 | 30 | 17 | 47 |
| 2016 12 | 66 | 23 | 89 |
| 2016 11 | 55 | 12 | 67 |
| 2016 10 | 95 | 23 | 118 |
| 2016 9 | 154 | 14 | 168 |
| 2016 8 | 81 | 9 | 90 |
| 2016 7 | 37 | 10 | 47 |
| 2016 5 | 3 | 0 | 3 |
| 2016 4 | 2 | 0 | 2 |
| 2016 2 | 2 | 0 | 2 |
| 2015 1 | 6 | 112 | 118 |
| 2015 12 | 12 | 98 | 110 |
Mostrar todo
